Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis

The presence of a pro-oxidant state in patients with schizophrenia may account for the increased risk of atherosclerosis and cardiovascular disease in this group and supports the potential utility of circulating biomarkers of oxidative stress for risk stratification and management. We investigated t...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	Angelo Zinellu, Stefania Sedda, Arduino A. Mangoni
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Subjects:	schizophrenia paraoxonase-1 paraoxonase arylesterase oxidative stress HDL cholesterol
Online Access:	https://www.mdpi.com/2076-3921/12/8/1484

Similar Items

Serum arylesterase and paraoxonase activities in patients with ovarian tumors
by: Slawomir Michalak, et al.
Published: (2014-12-01)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Gian Luca Erre, et al.
Published: (2022-11-01)

Serum Paraoxonase-1 Activity and Paraoxonase Q192 Gene Polymorphism in a Young, Healthy Population
by: Dilek GOGAS YAVUZ, et al.
Published: (2021-06-01)

Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure
by: H Toy, et al.
Published: (2009-02-01)

Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma
by: Feyza Dursun, et al.
Published: (2015-10-01)

Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
by: Nurhan Sarioglu, et al.
Published: (2015-02-01)

Arylesterase activity of paraoxonase 1 and intensity of oxidative processes in the blood of dialysis patients
by: L. Korol, et al.
Published: (2019-12-01)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
by: Arianna Romani, et al.
Published: (2020-05-01)

Effects of PON1 QR192 genetic polymorphism and paraoxonase, arylesterase activities on deep vein thrombosis
by: Akbalik Hasim, et al.
Published: (2023-05-01)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
by: George Awuku Asare, et al.
Published: (2018-03-01)

Relationship of Serum Paraoxonase Enzyme Activity and Thermal Burn Injury
by: Serap Yildirim, et al.
Published: (2012-12-01)

Study of Oxidative Stress Marker Serum Paraoxonase in Metabolic Syndrome
by: Mohit Rojekar, et al.
Published: (2016-09-01)

Comparison of Total Oxidative Stress, Total Antioxidant Capacity, and Paraoxonase, Arylesterase, and Lipid Peroxidase Levels in Aqueous Humor and Serum of Diabetic and Non-Diabetic Patients with Catarac
by: Cengiz Caner, et al.
Published: (2012-01-01)

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Kazuhiko Kotani, et al.
Published: (2021-04-01)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
by: Ajda Taler-Verčič, et al.
Published: (2020-12-01)

Correlation between Cholinesterase and Paraoxonase 1 Activities: Case Series of Pesticide Poisoning Subjects
by: S Austin Richard, et al.
Published: (2013-08-01)

Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development
by: Marija Vavlukis, et al.
Published: (2022-09-01)

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender
by: Hamit Yasar Ellidag, et al.
Published: (2016-12-01)

Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis
by: Jun Watanabe, et al.
Published: (2021-11-01)

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019-01-01)

Paraoxonase Activities in Metabolic Syndrome in Children and Adolescents
by: Arati Adhe-Rojekar, et al.
Published: (2018-01-01)

Baculovirus-mediated expression and purification of human serum paraoxonase 1A
by: Robert J. Brushia, et al.
Published: (2001-06-01)

Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases
by: Zahra Najafi Arab, et al.
Published: (2022-06-01)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
by: Xavier Gabaldó, et al.
Published: (2022-06-01)

Paraoxonase-1 Phenotype and Its Relationship with Mean Platelet Volume and Oxidative Stress in Coronary Artery Disease
by: Şahabettin SELEK, et al.
Published: (2015-08-01)

Paraoxonase-1 Concentrations in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis
by: Maria Carmina Pau, et al.
Published: (2022-04-01)

The effect of 16 weeks of aerobic training on activity of serum paraoxonase, arylesterase, and lipid profile in postmenopausal women
by: R ghasemi, et al.
Published: (2017-10-01)

Relationship of paraoxonase-1 and paraoxonase-3 with routine laboratory tests and oxidative stress in type 2 diabetes mellitus
by: Ucar Yagcı Yagmur, et al.
Published: (2024-09-01)

Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
by: Amirnader Emami Razavi, et al.
Published: (2013-06-01)

Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis
by: Oriana Simonetti, et al.
Published: (2021-04-01)

Paraoxonase 1 Activity and Survival in Sepsis Patients
by: Volkan İnal, et al.
Published: (2015-06-01)

Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents
by: Moushira Erfan Zaki, et al.
Published: (2014-01-01)

Do PON1–Q192R and PON1–L55M polymorphisms modify the effects of hypoxic training on paraoxonase and arylesterase activity?
by: Oya Yigittürk, et al.
Published: (2023-03-01)

Role of Paraoxonase 2 in Airway Epithelial Response to Oxidant Stress
by: Matthew S. McCravy, et al.
Published: (2024-10-01)

Caffeine Increases Apolipoprotein A-1 and Paraoxonase-1 but not Paraoxonase-3 Protein Levels in Human-Derived Liver (HepG2) Cells
by: Gülben Sayılan Özgün, et al.
Published: (2017-12-01)

Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01)

Paraoxonase 1 gene polymorphism and enzymatic activity as a prognostic marker in cases of poisoning by cholinesterase inhibitor pesticides among Egyptians
by: Dalia El-Neily, et al.
Published: (2017-01-01)

Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis
by: Farid Ayman, et al.
Published: (2012-07-01)

Antioxidant Status and Serum Prolidase Activity in Women with Subclinical Hypothroidism
by: Mehmet Ali Eren, et al.
Published: (2015-06-01)

Determination of paraoxonase enzyme and magnesium in women with arthritis in Balad city and evaluation of the correlation between them
by: Adnan Ali Sura, et al.
Published: (2025-01-01)